Clarus Therapeutics Holdings, Inc. (CRXTQ)

USD 0.0

(0.0%)

Total Debt Summary of Clarus Therapeutics Holdings, Inc.

  • Clarus Therapeutics Holdings, Inc.'s latest annual total debt in 2021 was 42.26 Million USD , down -67.25% from previous year.
  • Clarus Therapeutics Holdings, Inc.'s latest quarterly total debt in 2022 Q2 was 40.5 Million USD , up 5.25% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported annual total debt of 129.07 Million USD in 2020, down 0.0% from previous year.
  • Clarus Therapeutics Holdings, Inc. reported quarterly total debt of 38.48 Million USD for 2022 Q1, down 0.0% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported quarterly total debt of 42.26 Million USD for 2021 FY, down -67.25% from previous quarter.

Annual Total Debt Chart of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Historical Annual Total Debt of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Year Total Debt Total Debt Growth
2021 42.26 Million USD -67.25%
2020 129.07 Million USD 0.0%

Peer Total Debt Comparison of Clarus Therapeutics Holdings, Inc.

Name Total Debt Total Debt Difference
AstraZeneca PLC 28.58 Billion USD 99.852%
Bristol-Myers Squibb Company PFD CONV 2 41.46 Billion USD 99.898%
CSPC Pharmaceutical Group Limited 99.64 Million USD 57.581%
Novartis AG 26.34 Billion USD 99.84%
PT Kalbe Farma Tbk. 40.4 Million USD -4.611%